5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.57▼ | 1.60▼ | 1.60▼ | 1.58▼ | 1.46▲ |
MA10 | 1.55▼ | 1.50▲ | 1.50▲ | 1.47▲ | 1.54▲ |
MA20 | 1.46▲ | 1.42▲ | 1.42▲ | 1.39▲ | 1.85▼ |
MA50 | 1.44▲ | 1.47▲ | 1.48▲ | 1.55▲ | 1.96▼ |
MA100 | 1.63▼ | 1.67▼ | 1.68▼ | 1.83▼ | 1.94▼ |
MA200 | 1.84▼ | 1.97▼ | 1.95▼ | 1.86▼ | 3.96▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.013▲ | 0.028▲ | 0.030▲ | 0.047▲ | -0.031▼ |
RSI | 52.820▲ | 53.165▲ | 52.948▲ | 56.579▲ | 45.527▼ |
STOCH | 67.029 | 78.720 | 78.720 | 76.116 | 30.450 |
WILL %R | -51.429 | -50.434 | -50.434 | -34.937 | -62.295 |
CCI | 6.897 | 29.849 | 29.849 | 90.591 | -13.669 |
Thursday, April 24, 2025 04:59 AM
Norovirus GII.17 variants have overtaken GII.4 as the most prevalent strain and significantly increased norovirus outbreaks in the U.S. and European countries in 2024-2025Cocrystal Pharma’s pan-viral ...
|
Wednesday, April 16, 2025 05:00 PM
April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest ...
|
Wednesday, April 16, 2025 05:00 PM
April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.55 | 1.5942 | 1.5201 | 1.58 | 5,567 |
30/04/25 | 1.56 | 1.737 | 1.49 | 1.51 | 7,529 |
28/04/25 | 1.72 | 1.8109 | 1.6001 | 1.65 | 24,050 |
25/04/25 | 1.33 | 1.709 | 1.33 | 1.709 | 25,024 |
24/04/25 | 1.41 | 1.48 | 1.36 | 1.46 | 34,218 |
23/04/25 | 1.44 | 1.44 | 1.2318 | 1.4136 | 26,653 |
22/04/25 | 1.35 | 1.41 | 1.34 | 1.3911 | 11,269 |
21/04/25 | 1.35 | 1.35 | 1.30 | 1.3354 | 20,922 |
17/04/25 | 1.32 | 1.3436 | 1.31 | 1.31 | 1,728 |
16/04/25 | 1.37 | 1.3741 | 1.31 | 1.31 | 2,937 |
|
|
||||
|
|
||||
|
|